As an Institutional Review Board (IRB), IntegReview’s responsibility is to assure the protection of the rights and welfare of the research participants.
As a research participant, IntegReview recommends that you ask and ensure you have answers to the following questions before deciding to participate in a research study:
- What is the main purpose of the study?
- Does the study involve a placebo (inactive treatment, equivalent to a sugar pill) or a treatment/device that is already on the market?
- How will the study drug/device be given to me?
- How long is the study going to last and what will I be asked to do as a participant?
- What has been learned about the study drug/device and are any study results published?
- Do I have to pay for any part of the study? Will my insurance cover these costs?
- Will I be able to see my own doctor?
- If the study drug/device works for me, can I keep using it after the study?
- Can anyone find out whether I’m participating in the research study?
- Will I receive any follow-up care after the study has ended?
- What will happen to my medical care if I stop participating in the study?
- Am I comfortable with the doctor and study staff as they will be medical care providers during the study?
Helpful Links regarding clinical research participation
Once you have completed participation in a research study, please feel free to complete IntegReview’s Research Participant Survey to offer any feedback on the informed consent document.
You may obtain answers to questions regarding your rights as a research subject by dialing our main office number at (512) 326-3001 or express concerns via e-mail to integreview@integreview.com.